Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine
Gábor G. Kovács
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 2, pp. 189-189
Open Access | Times Cited: 279

Showing 1-25 of 279 citing articles:

Using machine learning approaches for multi-omics data analysis: A review
Parminder Singh Reel, Smarti Reel, Ewan R. Pearson, et al.
Biotechnology Advances (2021) Vol. 49, pp. 107739-107739
Open Access | Times Cited: 527
Tau and tauopathies
Thomas Arendt, Jens Stieler, Max Holzer
Brain Research Bulletin (2016) Vol. 126, pp. 238-292
Closed Access | Times Cited: 520
Autism genetics: opportunities and challenges for clinical translation
Jacob Vorstman, Jeremy Parr, Daniel Moreno‐De‐Luca, et al.
Nature Reviews Genetics (2017) Vol. 18, Iss. 6, pp. 362-376
Open Access | Times Cited: 415
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Leda Mezzaroba, Daniela Frizon Alfieri, Andréa Name Colado Simão, et al.
NeuroToxicology (2019) Vol. 74, pp. 230-241
Closed Access | Times Cited: 412
What is the evidence that tau pathology spreads through prion-like propagation?
Amritpal Mudher, Morvane Colin, Simon Dujardin, et al.
Acta Neuropathologica Communications (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 326
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant, et al.
The World Journal of Biological Psychiatry (2017) Vol. 19, Iss. 4, pp. 244-328
Open Access | Times Cited: 259
A walk through tau therapeutic strategies
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 248
Molecular biomarkers of Alzheimer's disease: progress and prospects
Tammaryn Lashley, Jonathan M. Schott, Philip S.J. Weston, et al.
Disease Models & Mechanisms (2018) Vol. 11, Iss. 5
Open Access | Times Cited: 206
Molecular pathology of neurodegenerative diseases: principles and practice
Gábor G. Kovács
Journal of Clinical Pathology (2019) Vol. 72, Iss. 11, pp. 725-735
Open Access | Times Cited: 190
Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
Jennifer Ngolab, Ivy Trinh, Edward Rockenstein, et al.
Acta Neuropathologica Communications (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 189
Tauopathies
Gábor G. Kovács
Handbook of clinical neurology (2017), pp. 355-368
Closed Access | Times Cited: 186
Concepts and classification of neurodegenerative diseases
Gábor G. Kovács
Handbook of clinical neurology (2017), pp. 301-307
Closed Access | Times Cited: 177
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 5, pp. 265-284
Open Access | Times Cited: 162
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Murtala Bello Abubakar, Kamaldeen Olalekan Sanusi, Azizah Ugusman, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 162
The emerging role of α-synuclein truncation in aggregation and disease
Zachary A. Sorrentino, Benoit I. Giasson
Journal of Biological Chemistry (2020) Vol. 295, Iss. 30, pp. 10224-10244
Open Access | Times Cited: 141
Aggregation of Disordered Proteins Associated with Neurodegeneration
Phoebe S. Tsoi, My Diem Quan, Josephine C. Ferreon, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3380-3380
Open Access | Times Cited: 56
The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle
Yu Cai, Yin Zhang, Shuo Leng, et al.
Neurobiology of Disease (2024) Vol. 192, pp. 106426-106426
Open Access | Times Cited: 17
Genistein: A Promising Ally in Combating Neurodegenerative Disorders
Diksha Sharma, Varinder Singh, Amit Kumar, et al.
European Journal of Pharmacology (2025), pp. 177273-177273
Closed Access | Times Cited: 2
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
Kira Sheinerman, Jon B. Toledo, Vladimir Tsivinsky, et al.
Alzheimer s Research & Therapy (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 159
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)
Peter T. Nelson, John Q. Trojanowski, Erin L. Abner, et al.
Journal of Neuropathology & Experimental Neurology (2016) Vol. 75, Iss. 6, pp. 482-498
Open Access | Times Cited: 141
Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies
Christiana Kontaxi, Pedro Piccardo, Andrew C. Gill
Frontiers in Molecular Biosciences (2017) Vol. 4
Open Access | Times Cited: 125
Small-molecule PET Tracers for Imaging Proteinopathies
Chester A. Mathis, Brian J. Lopresti, Miloš D. Ikonomović, et al.
Seminars in Nuclear Medicine (2017) Vol. 47, Iss. 5, pp. 553-575
Open Access | Times Cited: 109
Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry
Nobuto Kakuda, Tomohiro Miyasaka, Noriyuki Iwasaki, et al.
Acta Neuropathologica Communications (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 109
Fluid Biomarkers for Synaptic Dysfunction and Loss
Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Biomarker Insights (2020) Vol. 15, pp. 117727192095031-117727192095031
Open Access | Times Cited: 109
The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
Ito Kawakami, Tetsuaki Arai, Masato Hasegawa
Acta Neuropathologica (2019) Vol. 138, Iss. 5, pp. 751-770
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top